New England Research & Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,200	Closed	-$209K	–	168
2018 Q1	$209K	Buy	+4,200	New	+$209K	0.14%	151
2017 Q3	–	Sell	-8,795	Closed	-$434K	–	156
2017 Q2	$434K	Sell	8,795 -1,500	-15%	-$74K	0.32%	101
2017 Q1	$447K	Buy	+10,295	New	+$447K	0.34%	96